Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1848 (LINC01848)
- Target
- LINC01848
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 1848 (LINC01848) is classified as a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs that are transcribed from genomic regions located between protein-coding genes and do not overlap coding sequences[5]. LincRNAs, including LINC01848, typically exceed 200 nucleotides in length and are transcribed by RNA polymerase II[5]. While many lincRNAs have been shown to play roles in gene regulatory networks, chromatin state modulation, and epigenetic regulation, not all lincRNAs have characterized biological functions, and specific information about the function or disease relevance of LINC01848 is currently lacking in the biomedical literature[5][3]. Therefore, it is not considered a therapeutic target, receptor, enzyme, transporter, or similar molecule at this time.
- Other names
- LINC01848long intergenic non-coding RNA 1848lincRNA 1848
02
Biological functions
Gene regulation (notably, regulation of gene expression at the transcriptional or epigenetic level, typical of lincRNAs)Chromatin modification (generally lincRNAs can interact with chromatin-modifying complexes)Other
03
Disease associations
Other (while some lincRNAs are implicated in cancer or cellular stress responses, there is currently no evidence specifically linking LINC01848 to cancer, inflammation, or other defined disease settings)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1848 (LINC01848).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1848 (LINC01848).